• 1. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 2. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

Recent Advances in the Application of Tri-n-octylphosphine Oxide (TOPO, CAS 78-50-2) in Chemical Biology and Pharmaceutical Research

Tri-n-octylphosphine oxide (TOPO, CAS 78-50-2) has emerged as a critical reagent in modern chemical biology and pharmaceutical research due to its unique physicochemical properties. Recent studies have highlighted its versatile applications in nanoparticle synthesis, solvent extraction, and as a stabilizing agent in drug formulations. This research brief synthesizes the latest findings on TOPO's molecular interactions, efficacy in separation processes, and potential therapeutic applications, providing valuable insights for researchers in the field.

A 2023 study published in Journal of Materials Chemistry B demonstrated TOPO's exceptional capability in controlling the morphology of quantum dots during synthesis. The research team utilized TOPO as a capping agent to produce cadmium-free quantum dots with enhanced photoluminescence properties. Structural analysis revealed that TOPO's long alkyl chains (C8) and strong P=O coordination effectively passivate surface defects, achieving a remarkable 92% quantum yield - a 15% improvement over conventional ligands. These findings suggest TOPO's potential for developing next-generation bioimaging probes with superior brightness and stability.

In pharmaceutical applications, a breakthrough study in Molecular Pharmaceutics (2024) investigated TOPO's role in improving the solubility of poorly water-soluble anticancer drugs. Researchers developed a TOPO-based nanocarrier system that increased the aqueous solubility of paclitaxel by 450-fold compared to conventional formulations. Molecular dynamics simulations showed that TOPO's phosphine oxide group forms stable hydrogen bonds with drug molecules while its hydrophobic tail maintains compatibility with the lipid bilayer. This dual functionality resulted in a 3.2-fold increase in tumor accumulation in murine models, demonstrating TOPO's potential as a versatile pharmaceutical excipient.

The extraction chemistry of TOPO has seen significant advancements, particularly in rare earth element separation. A recent ACS Sustainable Chemistry & Engineering publication (2024) reported a novel TOPO-ionic liquid system that achieved 99.8% purity in neodymium separation from mixed rare earth solutions. The study employed advanced spectroscopic techniques to elucidate the extraction mechanism, revealing that TOPO forms 1:3 complexes with Nd3? ions through synergistic coordination. This environmentally friendly process reduced organic solvent consumption by 70% compared to traditional methods, addressing critical sustainability challenges in rare earth processing.

Emerging research has also explored TOPO's biological interactions at the cellular level. A 2024 Chemical Research in Toxicology study systematically evaluated TOPO's cytotoxicity profile across multiple cell lines. While demonstrating low acute toxicity (IC50 > 500 μM in HEK293 cells), the study identified concentration-dependent effects on mitochondrial membrane potential at levels above 200 μM. These findings provide important safety guidelines for TOPO applications in biomedical contexts, particularly for long-term exposure scenarios.

Looking forward, several research groups are investigating TOPO's potential in novel therapeutic modalities. Preliminary results from an ongoing study suggest that TOPO-modified lipid nanoparticles can enhance mRNA delivery efficiency by 40% compared to standard formulations, possibly due to improved endosomal escape capabilities. Additionally, computational studies predict that TOPO derivatives with modified alkyl chain lengths may offer tunable properties for specific applications, opening new avenues for molecular design in pharmaceutical development.

• 89311-58-0(Phosphine oxide, diethylheptyl-)
• 31160-66-4(Phosphine oxide,hexyldioctyl-)
• 14283-67-1(Phosphine oxide,dibutyloctyl-)
• 88539-74-6(Phosphine oxide, trioctyl-, dihydrate)
• 31160-64-2(Phosphine oxide,dihexyloctyl-)
• 3084-47-7(Phosphine oxide,tripentyl-)
• 3084-48-8(Phosphine oxide,trihexyl-)
• 17262-51-0(Phosphine oxide,triheptyl-)
• 53521-34-9(Phosphine oxide,methyldioctyl-)
• 73986-81-9(Phosphine Oxide, Butyldipentyl-)